Initial Regimen
150 results
1 - 100Initial Regimen
- DEFINITION
- INDICATIONS
- DHHS Guidelines (11/2019): Recommended Initial Regimens for Most People with HIV
- DHHS Guidelines (11/2019): Recommended initial regimen in certain clinical situations
- DHHS Guidelines (11/2019): Other
- IAS-USA Guidelines (2018)
- CLINICAL RECOMMENDATION
- General
- Integrase Inhibitor-Based Regimens
- NNRTI-Based Regimens
- PI-Based Regimens
- Choice of NRTI Backbone (as component of HAART regimen)
- Use of Other Agents
- Chronic Liver Disease/Viral Hepatitis
- Renal Insufficiency
- Pregnancy or Child-bearing Potential
- References
Leishmania species
Histoplasmosis
Zidovudine (AZT)
Trogarzo
Induction-Maintenance
Retroviral Syndrome, Acute
Lamivudine
Antiretroviral Therapy: Treatment-Experienced Patients
Resistance testing: genotype
Raltegravir
Viral load assays
Lymphoma, Hodgkin
Nevirapine
Lopinavir/ritonavir
Mycobacterium avium complex (MAC), disseminated
Primary HIV Infection
Rhodococcus equi
Pregnancy and perinatal transmission
Progressive multifocal leukoencephalopathy (PML)
Toxicity & side effects: switching therapy
CD4 Cell Count
When to Start Therapy: Chronic HIV Infection
Cabotegravir + Rilpivirine
Glecaprevir + Pibrentasvir
Maraviroc
Elvitegravir
Baseline & routine testing
Atazanavir
Tenofovir DF
Tuberculosis, Active
Didanosine
Stavudine
Narcotic Analgesics
Diabetes Mellitus and Insulin Resistance
Mycobacterium kansasii
Nocardiosis
Depression
Candidiasis, esophageal
Efavirenz
Thrombocytopenia
Virologic failure: When to modify therapy
Tenofovir alafenamide (TAF)
Pneumocystis pneumonia
Human papillomavirus (HPV)
Saquinavir
Trimethoprim + Sulfamethoxazole
Rifabutin
Abacavir
HIV, Occupational Exposure
Nelfinavir
Staphylococcus spp.
Salmonella spp.
Lenacapavir
Post-exposure prophylaxis
Anthrax vaccine
Monitoring Therapy
Streptococcus pneumoniae
Sofosbuvir + Ledipasvir
Ganciclovir
Levofloxacin
Telaprevir